FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

154281000036109: betamethasone (as acetate) 2.71 mg / 1 mL + betamethasone (as sodium phosphate) 2.96 mg / 1 mL injection, 1 mL ampoule (medicinal product unit of use)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    733411000036111 betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule en Synonym Active Case sensitive Australian Medicines Terminology module
    745971000036114 betamethasone (as acetate) 2.71 mg / 1 mL + betamethasone (as sodium phosphate) 2.96 mg / 1 mL injection, 1 mL ampoule (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule Is a medicinal product unit of use false Inferred relationship Some
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule Is a betamethasone acetate + betamethasone sodium phosphate false Inferred relationship Some
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has intended active ingredient betamethasone acetate false Inferred relationship Some 1875096469
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has Australian BoSS betamethasone false Inferred relationship Some 1875096469
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has intended active ingredient betamethasone sodium phosphate false Inferred relationship Some 1833064809
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has Australian BoSS betamethasone false Inferred relationship Some 1833064809
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has manufactured dose form injection false Inferred relationship Some
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule has unit of use ampoule false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Celestone Chronodose injection: suspension, ampoule Is a False betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule Inferred relationship Some
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules has MPUU False betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start